Fabtech Technologies IPO saw full subscription by the second day, with 1,21,11,225 shares bid for. The company offers turnkey ...

Fabtech Technologies Ltd's IPO, targeting the pharmaceutical, biotech, and healthcare sectors, was subscribed 2.03 times by ...

LB Pharmaceuticals’ public listing comes amid a dry spell for biotech IPOs despite a flurry of activity early in 2025.

Sheel Biotech, specializing in biotechnology-driven agriculture solutions, announced its Rs 34.02 crore IPO. With a price ...

Fabtech Technologies IPO: The initial public offering (IPO) of Fabtech Technologies Limited entered its final day of public ...

The company, which is developing a competitor to Cobenfy, aims to become one of rare biotechs to price a large IPO of late.

MapLight Therapeutics, the second biotech to launch a Nasdaq bid this month, is a neuro-focused company advancing treatments ...

Korea biotech Adele fails technology evaluation, IPO relaunch delayed after investor re-pricing Adeles failed BBB ratings ...

Fabtech Technologies IPO opens today, Sept 29. Check key details including price band, lot size, grey market premium, listing ...

Four mainboard and 16 SME IPOs open for subscription next week — explore key dates, listing info, and how to invest now!

So much for the dog days of summer. During July, 6 more biotech companies took a running leap through the wide-open IPO window, joining a growing pool of newly made ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other industries as biotechnology has delivered only subpar investor returns. Only five ...